HLSE:ORNBVPharmaceuticals
How Investors Are Reacting To Orion Oyj (HLSE:ORNBV) Upgraded 2025 Profit Guidance And Stronger Momentum
Earlier in December 2025, Orion Oyj raised its full-year 2025 guidance, now expecting net sales of €1.82 billion–€1.90 billion and operating profit of €590 million–€670 million, up from its previous ranges.
The significantly higher profit outlook versus earlier guidance suggests Orion sees stronger-than-anticipated momentum across its core operations heading into year-end 2025.
Next, we will examine how Orion’s upgraded 2025 operating profit guidance reshapes the company’s investment...